-+ 0.00%
-+ 0.00%
-+ 0.00%

Tvardi Therapeutics Q2 EPS $(0.69) Beats $(0.70) Estimate

Benzinga·08/14/2026 11:07:14
Listen to the news
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.70) by 1.43 percent. This is a 31 percent increase over losses of $(1.00) per share from the same period last year.